Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration
Not yet recruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
September 30, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Conditions
Anti-Tumor Drug-Associated Interstitial Pneumonia
All Listed Sponsors
lead
Fuzhou University Affiliated Provincial Hospital
OTHER
NCT07190703 - Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration | Biotech Hunter | Biotech Hunter